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ABSTRACT NaeI is a remarkable type II restriction en-
donuclease. It must bind two recognition sequences to cleave
DNA, forms a covalent protein–DNA intermediate, and is only
1 aa change away from topoisomerase and recombinase
activity. The latter activities apparently derive from reactiva-
tion of a cryptic DNA ligase active site. Here, we demonstrate
that NaeI has two protease-resistant domains, involving ap-
proximately the N-terminal and C-terminal halves of the
protein, linked by a protease-accessible region of 30 aa. The
domains were purified by cloning. The C-terminal domain was
shown by gel mobility-shift assay to have approximately 8-fold
lower DNA-binding ability than intact NaeI. Analytical ultra-
centrifugation showed this domain to be a monomer in
solution. The N-terminal domain, which contains the catalytic
region defined by random mutagenesis, did not bind DNA and
was a mixture of different-sized complexes in solution imply-
ing that it mediates self-association. DNA greatly inhibited
proteolysis of the linker region. The results identify the
DNA-binding domain, imply that DNA cleavage and recogni-
tion are independent and separable, and lead us to speculate
about a cleft-like structure for NaeI.
Restriction endonuclease NaeI appears to have special mech-
anistic and evolutional importance. Showing its unusual her-
itage, NaeI must bind two DNA sequences to cleave DNA (1,
2). In addition, NaeI is the first restriction enzyme found to
form a transient covalent intermediate with its newly cleaved
substrate (3) much like the topoisomerases and recombinases.
Finally, a single amino acid change, leucine to lysine at position
43 (L43K), radically transforms NaeI into a topoisomerase (3)
and changes DNA recognition from double-stranded GCCy
GGC to a preference for DNA containing unpaired bases (4).
The L43K amino acid change is in a ligase-like active site that
lies just upstream of the putative catalytic region (5). The
ability of NaeI to act either as a restriction endonuclease or
topoisomerase-recombinase depending on a single amino acid
change is especially intriguing because NaeI has no detectable
sequence homology with the topoisomerase or recombinase
protein families. The unusual characteristics of NaeI suggest
that it is either in the process of evolving from a topoisomerase
to a restriction enzyme by abolishing its religation activity (3,
4) or may be able to serve both functions in vivo. NaeI may
represent a missing link between some endonucleases and the
topoisomerases and recombinases (4).
NaeI is a 317-aa polypeptide, has a molecular mass of 35 kDa
(6), and forms a dimer in solution (Mr 5 70) both in the
absence and in the presence of cognate DNA (7). NaeI loops
out DNA intervening distant NaeI DNA recognition se-
quences (8). This ability to loop out intervening sequences in
DNA is highly unusual for a restriction enzyme but consistent
with the requirement that NaeI bind two recognition se-
quences to activate DNA cleavage (1, 2).
Random mutagenesis shows that NaeI endonuclease has at
least two functional regions: a region located within the
N-terminal half of NaeI that mediates substrate binding and
catalysis, and another region located within the C-terminal half
of NaeI that binds DNA (5). We set out to map the protein-
folding domains of NaeI for comparison with the regions
defined by random mutagenesis, and to test whether the
catalytic and DNA-binding functions could be separated by
proteolysis. This knowledge is important because type II
restriction endonucleases divide into subclasses in which se-
quence recognition and catalysis at the primary sequence level
are either intertwined as in BamHI, EcoRI, EcoRV, and PvuII
(reviewed in ref. 9) or independent as in FokI (10). Knowledge
of these domains will enable comparison with the known
domain structures of restriction endonucleases and other
protein families. The comparisons may offer clues to how these
protein families are related.
Proteolytic cleavage provides a direct probe of protein
folding. Regions of proteins accessible to proteases generally
occur in extended linker regions or loops between tightly
folded domains that are exposed on the surface of the protein
(11). The domains can usually be purified for further analysis.
These methods have been used to identify the DNA-binding
domains of several sequence-specific DNA-binding proteins
(12–20). Here, we use these methods to map the domain
organization of NaeI. NaeI protein was overexpressed by using
a maltose-binding protein (MBP) fusion system. The purified
fusion protein had similar activity to wild-type NaeI. Limited
proteolysis of NaeI apoenzyme demonstrated two major do-
mains resistant to proteolysis, encompassing almost the entire
N-terminal and C-terminal halves of the protein, linked by a
region relatively accessible to cleavage by both trypsin and
chymotrypsin. The two protease-resistant domains were
cloned, expressed as MBP fusions, and analyzed for DNA
cleavage activity and specific DNA binding. The C-terminal
domain was found to be a monomer in solution and bound
DNA containing cognate recognition sequence with a KD
8-fold higher than that of NaeI. The N-terminal domain did not
show DNA-binding ability and self-associated to give various-
sized complexes in solution. The presence of DNA greatly
reduced the susceptibility of the linker region to proteases. The
change in susceptibility is the first indication of a protein
conformational change associated with the switch from the
inactive to active form of NaeI upon DNA binding (1).
MATERIALS AND METHODS
Materials. Amylose resin and protein molecular weight
markers were purchased from New England Biolabs. G-50
Sephadex, S-Sepharose, Q-Sepharose, and Phosphocellulose
resin were purchased from Sigma. Escherichia coli strainThe publication costs of this article were defrayed in part by page charge
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CAA1 (F2 e142 (mcrA2) lacY1 or D(lac)6 SupE44 galK2
galT22 mcrA rfbD1 mcrBa hsd(rk2mk1) MzMspI1) and plasmid
pNEB786, containing the naeIR gene, were obtained from
New England Biolabs. Bovine factor Xa was obtained from
Haematologic Technologies (Burlington, VT).
Protein Purification. The NaeIR gene and two NaeIR gene
fragments were amplified from pNEB786 by PCR (21) and
inserted into the plasmid vector pMALc2 (New England
Biolabs) to give pMALc2:NaeI, pMALc2:NaeIDC172,
pMALc2:NaeIDN168. The insertions were downstream from
the malE gene, which encodes MBP and a factor Xa cleavage
site so that either MBP::NaeI or, after cleavage with factor Xa,
NaeI proteins could be isolated. Plasmid pMALc2:NaeI was
transformed into E. coli strain CAA1 and selected on Luria–
Bertani plates containing ampicillin (100 mgyml). Twelve-liter
cultures were grown from single colonies with aeration at
25–30°C. MBP::NaeI expression was induced with isopropyl
b-D-thiogalactoside (0.5 mM), grown for an additional 6–8 hr,
and harvested by centrifugation. Cell pellets were resus-
pended, washed in 0.9% NaCl, collected by centrifugation, and
either processed or stored frozen. Cell pellets were resus-
pended in 4 volumes of column buffer (10 mM TriszHCl (pH
7.4), 0.1 mM EDTA, 5% glycerol, 1 mM 2-mercaptoethanol, 50
mM NaCl). Phenylmethylsulfonyl f luoride (PMSF) was added
to 1 mM, to inhibit serine proteases. The resuspended cells
were sonicated on ice (1 min per each 10 ml) and immediately
centrifuged at 30,000 3 g for 30 min to remove cellular debris.
MBP::NaeI represented about 30% of total protein. Cell-
free extract was passed over amylose resin equilibrated in
column buffer plus 350 mM NaCl. Bound protein was eluted
with 10 mM maltose in column buffer (fraction 2), which
contained .70% of total protein as MBP::NaeI. Fraction 2 was
further purified by phosphocellulose chromatography using a
NaCl gradient (50 mM–1 M NaCl in column buffer). Active
fractions (225 mM NaCl) were pooled (fraction 3). For free
NaeI protein, fraction 3 was digested with factor Xa (0.2% of
total protein by weight) at 4°C for 48 hr (fraction 4), dialyzed
in NaeI storage buffer (column buffer without glycerol), and
purified by S-Sepharose column chromatography by using
storage buffer and a NaCl gradient (50 mM–1 M). Active
fractions were pooled (fraction 5) and a minor amount of
uncleaved MBP::NaeI protein was removed by using amylose
resin (fraction 6). By these methods, NaeI was purified to
.95%. MBP::NaeI(1–145) and MBP::NaeI(169–317) were
purified by amylose resin chromatography. NaeI(169–317) was
released from the fusion protein using factor Xa and purified
to greater than 90% using phosphocellulose for further study.
Limited Proteolysis of NaeI. Trypsin and chymotrypsin
(Boehringer Mannheim) digestions were performed by adding
at 37°C either 32 ng of trypsin or 1.6 mg of chymotrypsin in 16
ml of protease reaction buffer (10 mM TriszHCl, pH 8.0y0.1
mM EDTA, pH 8.0y1 mM 2-mercaptoethanoly100 mM
NaCly5% glyceroly5 mM CaCl2) to 200 ml of protease reaction
buffer containing 160 mg of purified NaeI. At various time
points, 31-ml aliquots were removed and added to 0.3 ml of
PMSF (100 mM in pure ethanol) to stop the reaction. SDS was
added to 1%, the aliquots were heated to 100°C for 5 min, and
reaction products were resolved by SDSyPAGE using 16%
polyacrylamide gels. Gels were either stained with Coomassie
brilliant blue-G250 or electroblotted onto poly(vinylidene
difluoride) (PVDF) membrane for protein sequencing (22).
Amino Acid Sequence Analysis. Polypeptide fragments were
visualized as bands on PVDF membrane by staining with
Ponceau S in water. Individual bands were cut from the
membrane and subjected to N-terminal amino acid sequencing
by the University of North Carolina Micro Protein Chemistry
Facility using a Perkin–ElmeryABI model 492 Precise instru-
ment. The sequence of the first seven amino acid residues was
determined for each fragment analyzed.
DNA Cleavage Activity Assays. DNA cleavage activities of
NaeI constructs were routinely monitored by examining their
ability to cleave 0.5 mg of pBR322 as described elsewhere (3).
Gel Mobility-Shift Assays. Radiolabeled single-stranded
deoxyribooligonucleotide (oligonucleotide) was annealed to
complementary oligonucleotide to give cognate and noncog-
nate probe DNAs. Probes were incubated with protein in a
20-ml reaction volume containing 10 mM TriszHCl (pH 8.0), 10
mM CaCl2, 20 mM NaCl, 10% glycerol, and BSA (0.1 mgyml)
for 20 min at room temperature. Cognate duplex DNA se-
quence was TTTCTCGCCACGTTCGCCGGCTTTC-
CCCGTCAAGCT; recognition sequence (underlined) was
substituted by GAAGAA to give noncognate DNA. Reactions
were immediately loaded onto 6 or 10% polyacrylamide
nondenaturing gels and fractionated by electrophoresis as
previously described (7). Results were analyzed by using a
PhosphorImager (Molecular Dynamics).
Effect of DNA Binding on Proteolysis of NaeI. To assess the
effect of DNA binding on proteolysis of NaeI, 80 mg of NaeI
in 100 ml of protease reaction buffer was incubated on ice for
30 min in the presence and absence of 107 mg of cognate DNA
(TTGGGTGCCGGCAGGGTC). Protease digestion at 37°C
was initiated by addition of 80 ng of trypsin or 800 ng of
chymotrypsin. At timed intervals, 14 ml aliquots of reaction
was mixed with 0.3 ml PMSF to terminate the reaction and
fractionated by SDSyPAGE. To determine whether DNA was
acting as a general protease inhibitor, this procedure was
repeated using 80 mg of mammalian cell cycle protein p27 (23),
which does not bind DNA, in place of NaeI.
Analytical Ultracentrifugation. The oligomeric states of
MBP-fusion proteins were determined by sedimentation ve-
locity measurements in a Beckman XL-A analytical ultracen-
trifuge. Fusion proteins were dialyzed in centrifugation buffer
containing 10 mM Tris (pH 7.4), 0.1 mM EDTA, 1 mM
2-mercaptoethanol, 100 mM NaCl, 10 mM maltose, and 5%
glycerol. Maltose ensures against oligomerization of MBP (24).
Samples (A280 5 1.5) were filtered (0.45 mm) and centrifuged
(12,000 rpm) to eliminate particulates. Protein samples (400
ml) were centrifuged at 50,000 rpm. Sedimentation boundary
was monitored by A280. Buffer density (1.0188 gyml) was
measured by specific gravity meter (DA-110M). Buffer vis-
cosity (0.0114 poise) was determined from composition. Pro-
tein partial specific volumes were determined from amino acid
composition (25). Molecular mass was derived from the Sved-
berg equation using the sedimentation coefficient (S) and
diffusion coefficient (D) determined by the second boundary
method (26), assuming globular spherical proteins with no
hydration. S and D were corrected to standard state (25) using
the AXIAL program (Les Holladay, Alza Corp., Palo Alto, CA).
Molecular mass was also determined by direct fit of sedimen-
tation velocity profile (27).
RESULTS
Proteolysis of NaeI Endonuclease. The absence of structural
information for NaeI led us to map the domain structure of
NaeI. By domains, we mean tightly folded regions of the
protein resistant to proteolysis with trypsin and chymotrypsin.
NaeI, purified as described in Materials and Methods, was
incubated with limiting amounts of trypsin and chymotrypsin
under conditions that digested the majority of full-length NaeI
within 90 min (Fig. 1). Digestion with trypsin gave essentially
three resistant fragments corresponding to molecular masses
of 16.6, 17.3, and 19.1 kDa, which we refer to as fragments
T16.6, T17.3, and T19.1 respectively. Digestion with chymo-
trypsin gave only two resistant fragments of approximately
13.5 (C13.5) and 19.1 (C19.1).
The N-terminal sequences of the stable fragments were
determined by automated protein sequencing (Table 1). The
protein fragment was mapped to the NaeI polypeptide by the
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N-terminal sequence of the fragment. Protein fragment length
was estimated from the molecular mass of the fragment as
determined by SDSyPAGE (Fig. 1). From the fragment’s
N-terminal sequence and apparent molecular mass we mapped
its location on the NaeI amino acid sequence as shown in Fig.
2. Based on this analysis, NaeI consists of two major protease-
resistant domains linked by a region susceptible to protease
cleavage. The protease-resistant domains reside within the
C-terminal and N-terminal halves of the protein. To analyze
the domains for DNA cleavage and binding, an attempt was
made to separate the fragments by using ion-exchange chro-
matography (S-Sepharose, Q-Sepharose, and Phosphocellu-
lose). The attempts failed to separate the two NaeI fragments
and may indicate strong interactions between the two frag-
ments. To overcome this problem, we cloned fragments of the
gene, representing approximately the N-terminal (amino acids
1–145) and C-terminal (amino acids 169–317) domains, fused
to MBP as described in Materials and Methods to give
MBP::NaeI(1–145) and MBP::NaeI(169–317), respectively.
Proteins MBP::NaeI(1–145), MBP::NaeI(169–317), and
MBP::NaeI were purified .70% over amylose resin columns.
DNA cleavage activities were examined by incubating up to 1
mg of each protein with pBR322. The specific activity of
MBP::NaeI was similar (within 2-fold) to that of native NaeI
purified by other methods (28), indicating that MBP fusion has
little effect on NaeI activity. Neither MBP::NaeI(169–317) nor
MBP::NaeI(1–145) alone nor when combined showed detect-
able DNA cleavage activity.
DNA Binding. Gel mobility-shift assays (29) were used as
described in Materials and Methods to determine whether
MBP::NaeI(1–145) and MBP::NaeI(169–317) (100 mM each)
could bind DNA. MBP::NaeI(169–317) showed strong binding
affinity for DNA with NaeI cognate recognition sequence. The
fraction of DNA bound was similar to that of the full-length
NaeI fusion protein. No DNA-binding activity (specific or
nonspecific) was detected for MBP::NaeI(1–145) at protein
concentrations of up to 1.1 mM (data not shown).
The ability of NaeI(169–317) to bind DNA was quantitated
and compared with that of NaeI after isolating the two
polypeptides free of MBP as described in Materials and
Methods. Apparent DNA-binding coefficients (KD), or con-
centration at which 50% of the DNA was bound by protein, for
NaeI and NaeI(169–317) binding to a 36-bp cognate DNA
were approximately 5 nM for NaeI and 40 nM for NaeI(169–
317) (Fig. 3).
FIG. 1. Coomassie brilliant blue stained SDS-polyacrylamide gel showing pattern of polypeptide fragments produced by limited trypsin and
chymotrypsin digestion of NaeI protein. The time of digestion is indicated along the tops of the lanes. The Mr of protease-resistant fragments
analyzed in this study are indicated alongside the gel image and are based on the molecular weight (MW) markers glutamic dehydrogenase (55,561
Da), maltose-binding protein (42,710 Da), lactate dehydrogenase (36,487 Da), triosephosphate isomerase (26,625 Da), trypsin inhibitor
(20,040–20,167 Da), lysozyme (14,313 Da), and aprotinin (6,517 Da). The digestion pattern at 0 min is caused by the amount of digestion taking
place during mixing and sampling.
FIG. 2. Map of the locations of the protease-resistant fragments
relative to full-length NaeI polypeptide. Also shown is the location of
the catalytic and DNA-binding regions mapped by random mutagen-
esis (5).












*Fragments are named according to protease treatment (T, trypsin; C,
chymotrypsin) and apparent molecular size of fragment (in kDa)
based on relative mobility during SDSyPAGE (e.g., T19.1 5 fragment
of approximately 19.1 kDa produced by trypsin digestion).
†Sequences shown were determined by automated amino acid se-
quencing of proteolytic reaction products as described in Materials
and Methods.
‡The sequence position of each polypeptide fragment is given as the
position of the first amino acid residue of the N-terminal end of the
fragment relative to the amino acid sequence of NaeI.
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Effect of DNA Binding on Proteolysis of NaeI. To gain
insight into the domains that either interact with DNA in the
intact NaeI molecule or undergo a conformational change
upon binding DNA, we compared the trypsin and chymotryp-
sin digestion pattern in the presence and absence of DNA. We
looked for regions of NaeI made either more sensitive or more
resistant by DNA binding. The DNA was shown not to be a
general inhibitor of either protease by incubation with mam-
malian cell cycle protein p27 (23) that does not bind DNA.
Protein p27 was found to be equally susceptible to protease
cleavage whether or not the DNA fragment was added to the
reaction (results not shown).
The protease digestion pattern of NaeI was determined in
the presence and absence of cognate DNA as described in
Materials and Methods. The digestion reactions were analyzed
by SDSyPAGE (Fig. 4). Digestion with both trypsin and
chymotrypsin was greatly attenuated by NaeI interaction with
DNA, and the chymotrypsin digestion pattern was altered as
well. Whereas the 13.5-kDa band was formed to a similar
extent whether or not DNA was present, formation of the
prominent 19.1-kDa band (corresponding to the C-terminal
domain) was inhibited when DNA was included in the reaction.
This indicates that the C terminus of the linker region is less
accessible after DNA binding than its N terminus. This con-
clusion is consistent with the complete loss of cleavage by
trypsin because trypsin only cleaves near the C terminus of the
linker region (see Fig. 2).
Self-Association. NaeI self-associates to form a dimer in solu-
tion (7). Analytical ultracentrifugation was used to determine the
abilities of the NaeI domains to self-associate. From the deter-
mination of sedimentation and diffusion coefficients, the appar-
ent molecular masses of MPB::NaeI, MPB::NaeI(1–145), and
MPB::NaeI(169–317) were calculated assuming spherical globu-
lar proteins with no hydration. Sedimentation of the two domains
and wild-type protein fused to MBP are shown in Fig. 5.
MBP::NaeI centrifugation shows the presence of two major
species (Fig. 5A). One, a rapidly sedimenting complex, is appar-
ently a mixture of various-sized complexes of NaeI. The other
major species showed a sedimentation coefficient of 5.125 3
10213 sec, diffusion coefficient of 3.46 3 1027 cm2ysec, and
molecular mass of 147 kDa as determined by direct fitting of the
sedimentation velocity profile (27). Similar values were obtained
by other methods as described in Materials and Methods. The
molecular mass determined is approximately two times the
molecular mass of the monomeric MBP::NaeI protein (78 kDa)
determined from its amino acid composition. Thus MBP::NaeI,
like NaeI (7) is a dimer in solution, and also gave a rapidly
sedimenting mixture of higher-ordered complexes that could be
resuspended by mixing and recentrifuged to give the same
sedimentation pattern. MBP::NaeI(169–317) showed the pres-
ence of a single species (Fig. 5B) with sedimentation coefficient
of 3.151 3 10213 sec, diffusion coefficient of 6.53 3 1027 cm2ysec,
and molecular mass of 47 kDa. The apparent molecular mass
value of 47 kDa is less than that determined from its amino acid
composition (59 kDa); we infer that MBP::NaeI(168–317) is a
monomer in solution. MBP::NaeI(1–145) showed a pattern cor-
responding to that expected for a mixture of higher-ordered
complexes similar to that seen in the preparation of MBP::NaeI
(Fig. 5C).
DISCUSSION
Domain Organization of NaeI. Limited digestion with tryp-
sin and chymotrypsin reveals that NaeI is composed of at least
two major domains that include amino acids 1–120 and 151–
317. These two domains are linked by a short protease-
sensitive region that includes amino acids 121–150. The bound-
aries of the protease-resistant domains approximately parallel
FIG. 3. Determination of apparent KD for NaeI and NaeI(169–317) binding to DNA using gel mobility-shift assay. DNA probe was cognate
36-mer double-stranded DNA (0.2 nM). The protein concentrations used in each reaction are shown above each lane. The reaction conditions are
described in Materials and Methods. The band intensities as a function of protein concentration were quantitated by densitometry and are plotted
in the graphs at the bottom.
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(Fig. 2) the two functional regions defined by random mu-
tagenesis (5). Cloning and characterization of the domains
demonstrated that only the C-terminal domain detectably
binds DNA. Thus, the separable N-terminal and C-terminal
domains appear to have independent functions. Mutagenic
studies imply that the N-terminal domain mediates catalysis:
The L43K substitution gives NaeI topoisomerase activity (3)
and T60I and E70K substitutions drastically reduce cleavage
activity without reducing DNA binding (5). Mutagenic studies
and the above DNA-binding results demonstrate that the
C-terminal domain mediates sequence-specific DNA binding.
Although it is clear from these studies that the C-terminal
domain is mainly responsible for DNA recognition, it is not
possible to fully rule out the presence in this domain of amino
acids that contribute to catalytic function. No essential cata-
lytic amino acids were located in this region by random
mutagenesis, but the level of mutagenesis was not saturating.
The apparent independence of the catalytic and DNA-
binding domains at the gene level is different from the type II
restriction endonucleases for which information is available.
For example, recognition and catalytic function are inter-
twined for BamHI, EcoRI, EcoRV, and PvuII (reviewed in ref.
9)—enzymes that recognize and cleave within a specific
sequence. On the other hand, FokI binds a specific recognition
sequence but cleaves nearby the sequence and has separable
recognition and catalytic domains (although not in the same
order as NaeI) (10). NaeI, therefore, may be unusual because
it cleaves within its recognition sequence, yet appears to have
separable functions. The domain structure of NaeI suggests it
may be more related to the IIs type endonucleases like FokI
than the type II enzymes like EcoRI.
DNA Binding. DNAs encoding the two protease-resistant
NaeI domains were cloned and overexpressed in E. coli.
Isolation of the peptides and analysis of their DNA-binding
abilities demonstrate that only the C-terminal domain has
detectable DNA-binding activity in solution. Measurements of
apparent KD for DNA binding show that the C-terminal
domain accounts for approximately an eighth of the DNA-
binding ability of intact NaeI. The C-terminal domain binds,
however, as a monomer. Cooperative binding as a dimer in the
wild-type protein could provide the missing binding energy.
The same DNA-binding measurements indicate that the
N-terminal domain does not detectably bind DNA. Care must
be taken, however, in concluding that the N-terminal domain
has no DNA-binding capability. Mutagenesis studies (5)
showed that some mutations in the N-terminal region modified
DNA binding. These effects could be caused by disruptions to
protein conformation that interfere with DNA binding to the
C-terminal domain. Also likely, weak stabilizing interactions
with DNA coming from the N-terminal domain, which must
interact with DNA to catalyze cleavage in the native enzyme,
may be undetectable when the N-terminal domain is separated
from the major DNA-binding C-terminal domain.
Self-Association. How NaeI dimerizes is important because
none of the known protein dimerization motifs are obvious
from the NaeI amino acid sequence. Analytical ultracentrifu-
gation demonstrated that the isolated N-terminal domain is a
mix of various-sized complexes. The ability of the N-terminal
FIG. 4. Coomassie brilliant blue stained SDS-polyacrylamide gel
showing pattern of polypeptide fragments produced by limited chymo-
trypsin (A) and trypsin (B) digestion of NaeI protein in the presence
or absence of DNA. Digestion times are shown above the lanes. The
Mr of protease-resistant fragments are indicated alongside the gel
image and are based on the molecular weight (MW) markers described
in the legend to Fig. 2.
FIG. 5. Analytical ultracentrifuge determination of molecular
weight of maltose-binding protein fusions with NaeI, and its N-
terminal and C-terminal domains. Centrifugation was at 50,000 rpm;
A280 boundary profiles are shown at 5, 10, 15, 20, 25, 30, 35, 40, and
45 min (from left to right). x-axis shows the radius of the sample cell
(from left to right is the direction of centrifugal force); y-axis shows the
A280 of the solution, measured through the sample cell. (A)
MBP::NaeI; (B) MBP::NaeI(169–317); (C) MPB::NaeI(1–145).
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domain of NaeI to form various-sized complexes in solution
implies that this domain mediates dimerization. Consistent
with this conclusion, the C-terminal domain was shown to be
a monomer in solution.
It is possible that self-association of the N-terminal domain
contributes to the lack of DNA binding by this domain. We
constructed other mutants with changes in the N-terminal
domain that also form various-sized complexes in solution. The
mutants bind DNA only if the C-terminal domain is intact
(J.D.C. and M.D.T., unpublished results). The results show
that formation of the various-sized complexes does not block
NaeI accessibility to DNA.
Effects of DNA Binding on Proteolysis of NaeI. Proteolysis
of NaeI was strongly inhibited by DNA. The inhibition can, in
principle, be explained by either of two models. In the first
model, DNA directly binding to the protease-sensitive linker
region blocks access of the protease and thus inhibits cleavage.
In the second model, binding of DNA to another region of the
protein induces a conformational shift in NaeI that reduces
access or sensitivity of the linker region to cleavage. The linker
region of NaeI (amino acids 121–150) has a concentration of
positive charges (5 of 12 residues) located toward its C
terminus. The involvement of this region in DNA direct
binding could explain why the addition of DNA more effec-
tively inhibits cleavage of the C terminus of the linker region
than it does the N terminus.
A Low-Resolution Model. Proteolysis demonstrates that
NaeI has two tightly folded domains linked by a hinge region.
The results imply independence of DNA binding and cleavage
at the gene sequence level and show large effects of DNA on
proteolysis of the hinge region. The requirement that both
domains interact with DNA for sequence-specific cleavage
leads us to speculate that docking of DNA in a crevice formed
by these domains rearranges the linker region and makes it less
accessible to protease. This low-resolution structure is consis-
tent with the recently reported structure for FokI in which
recognition and catalysis reside in separate domains (10); FokI
has become a target for attempts to design new cleavage
specificities based on domain swapping between proteins.
Perhaps NaeI will also be useful for this purpose. In FokI, the
cleavage domain is folded away from the DNA by protein–
protein interactions with the recognition domain (10). Appar-
ently, this provides a mechanism for avoiding DNA cleavage
until interaction with cognate recognition sequence when
DNA interactions cause the cleavage domain to swing over to
the DNA for cleavage (10, 30). Such a mechanism could also
apply to NaeI with its separate cleavage and recognition
domains apparently linked by a switch that is toggled by DNA
binding.
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